# Domain QA

## Status

pass

## Reviewed Inputs

- `docs/phase5-scope-register.md`
- `docs/playtest-findings-v0.1.19.md`
- `docs/first-scenario-brief.md`
- `docs/system-boundary.md`
- `docs/roadmap.md` Phase 5

## Findings

- Deferred actors (competitor, Medicare, Medicaid, patient cohorts) are listed
  in a dedicated Deferred section with rationale; they are not described as
  implemented strategic agents.
- Achieved interactions map to committed runtime modules and test evidence.
- Exit-criteria assessment cites playtest findings and replay/debrief tests rather
  than claiming empirical validation.
- Prototype integer formulas remain labeled as abstractions via cross-links to
  `evidence-registry.md` and `system-boundary.md`.
- Partial achievement of forecasts/uncertainty UI is documented honestly.

## Required Fixes

None.

## Residual Risks

- Readers may still conflate Phase 5 closure with full roadmap §5.1 world
  completeness; the register explicitly states §5.1 deferrals.
- External classroom use remains premature until governance docs and competitor
  slice land.
- Parameter ledger and calibration evidence still unresolved.

## Verification Evidence

- Docs-only slice; no `transition()` or ruleset changes.
- Golden seed-42 hash unchanged; runtime behavior preserved.
